Global Vaccines Market & Forecast (14 Vaccines Market, Number of People Immunized Doses of Vaccines Administered)
Global Vaccines Market to reach US$ 60 Billion by the year 2022. Pediatric vaccines market is having a dominant market share compared to Adult vaccines market. By 2022 Pediatric vaccines market share will be double the size of adult vaccines market share. Worldwide the number of infants immunized by influenza vaccines remain considerably low than that of adults immunized in year 2017. While the number of Rotavirus doses administered in infants is forecast to increase over the years and reach nearly 15 Million by the year 2022.
Adult Vaccine Market Share Analysis
Out of the total 9 Adult vaccines (Influenza, Cervical Cancer, Zoster, MMRV, Pneumococcal, Meningococcal, Hepatitis, TdaP, Travel) studied in the report Influenza vaccines dominates the adult vaccine market in 2017.
Pediatric Vaccine Market Share Analysis
Our analysis found that in year 2017; Pneumococcal and Combination vaccine together accounts for nearly 50% of the pediatric vaccine market share. Other Pediatric vaccines market studied in the report are as follows: Influenza, MMR, Pneumococcal, Meningococcal, Hepatitis, DTap, Haemophilus Influenzae Type b(Hib), Combos, Polio, Rotavirus, Varicella.
In 2017 Combos Vaccines will control the Immunization Share
For the year 2017; Combos (Combination Vaccines) has the maximum immunization share among all pediatric vaccines (Influenza, MMR, Pneumococcal, Meningococcal, Hepatitis, DTap, Haemophilus Influenzae Type b(Hib), Polio, Rotavirus, Varicella) studied in the report as they protect against more ailments in single shot, people preferring to get combination vaccine instead of a specific vaccine.
Administration of Vaccine Doses
Our analysis found that there is a consistent surge in the number of Pneumococcal and Meningococcal vaccine doses administration in future due to the rising concern against the life-threatening vaccine-preventable diseases around the world.
Global Vaccines Market & Forecast (14 Vaccines Market, Number of People Immunized Doses of Vaccines Administered) is the 8th edition of market research report published by Renub Research on Global Vaccines Market. This is a 318 page report with 193 Figures and 44 Tables provides data of Global Vaccine Market (Adult & Pediatrics), People Immunized, Number of Vaccine Doses Administered (Disease wise) & Key Players. Vaccine has been extensively studied from 3 major points, and further sub-divided into 2 more points:
1. World Vaccines (Disease wise) Market & Forecast (2011 – 2022)
a. Adult Vaccines Market & Forecast
b. Pediatrics Vaccines Market & Forecast
2. People Immunized (Disease wise) & Forecast (2011 – 2022)
a. Adult Immunized & Forecast
b. Pediatric (Infants) Immunized & Forecast
3. Doses of Vaccines Administered (Disease wise) & Forecast (2011 – 2022)
a. Doses of vaccines administered in Adults & Forecast
b. Doses of vaccines administered in Pediatric (Infants) & Forecast
14 Vaccines Studied in the Report are as Follows:
1. Influenza
2. Cervical Cancer
3. Zoster (Shingles)
4. MMR (Measles, Mumps, and Rubella)
5. Pneumonia
6. Meningitis
7. Hepatitis
8. Tap (Diphtheria, Tetanus, Pertussis)
9. Haemophilus influenzae type B
10. Polio
11. Rotavirus
12. Varicella
13. Combination Vaccine
14. Travel & Miscellaneous Vaccine
WHY THIS REPORT A COMPULSORY BUY!
Adult Vaccine Market Share Analysis
Out of the total 9 Adult vaccines (Influenza, Cervical Cancer, Zoster, MMRV, Pneumococcal, Meningococcal, Hepatitis, TdaP, Travel) studied in the report Influenza vaccines dominates the adult vaccine market in 2017.
Pediatric Vaccine Market Share Analysis
Our analysis found that in year 2017; Pneumococcal and Combination vaccine together accounts for nearly 50% of the pediatric vaccine market share. Other Pediatric vaccines market studied in the report are as follows: Influenza, MMR, Pneumococcal, Meningococcal, Hepatitis, DTap, Haemophilus Influenzae Type b(Hib), Combos, Polio, Rotavirus, Varicella.
In 2017 Combos Vaccines will control the Immunization Share
For the year 2017; Combos (Combination Vaccines) has the maximum immunization share among all pediatric vaccines (Influenza, MMR, Pneumococcal, Meningococcal, Hepatitis, DTap, Haemophilus Influenzae Type b(Hib), Polio, Rotavirus, Varicella) studied in the report as they protect against more ailments in single shot, people preferring to get combination vaccine instead of a specific vaccine.
Administration of Vaccine Doses
Our analysis found that there is a consistent surge in the number of Pneumococcal and Meningococcal vaccine doses administration in future due to the rising concern against the life-threatening vaccine-preventable diseases around the world.
Global Vaccines Market & Forecast (14 Vaccines Market, Number of People Immunized Doses of Vaccines Administered) is the 8th edition of market research report published by Renub Research on Global Vaccines Market. This is a 318 page report with 193 Figures and 44 Tables provides data of Global Vaccine Market (Adult & Pediatrics), People Immunized, Number of Vaccine Doses Administered (Disease wise) & Key Players. Vaccine has been extensively studied from 3 major points, and further sub-divided into 2 more points:
1. World Vaccines (Disease wise) Market & Forecast (2011 – 2022)
a. Adult Vaccines Market & Forecast
b. Pediatrics Vaccines Market & Forecast
2. People Immunized (Disease wise) & Forecast (2011 – 2022)
a. Adult Immunized & Forecast
b. Pediatric (Infants) Immunized & Forecast
3. Doses of Vaccines Administered (Disease wise) & Forecast (2011 – 2022)
a. Doses of vaccines administered in Adults & Forecast
b. Doses of vaccines administered in Pediatric (Infants) & Forecast
14 Vaccines Studied in the Report are as Follows:
1. Influenza
2. Cervical Cancer
3. Zoster (Shingles)
4. MMR (Measles, Mumps, and Rubella)
5. Pneumonia
6. Meningitis
7. Hepatitis
8. Tap (Diphtheria, Tetanus, Pertussis)
9. Haemophilus influenzae type B
10. Polio
11. Rotavirus
12. Varicella
13. Combination Vaccine
14. Travel & Miscellaneous Vaccine
WHY THIS REPORT A COMPULSORY BUY!
- This report offers complete analysis of Disease wise Global Vaccines Market & Forecast (2011 – 2022).
- This report offers segmented analysis of Disease wise Global Vaccines Market into two segments:
- Adult Vaccines (Disease wise) Market &Forecast
- Pediatric (Infant) Vaccines (Disease wise) Market &Forecast
- This report offers extensive analysis of the number of people Immunized and Number of Vaccines Doses Administered & Forecast (2011 – 2022) by Adult & Pediatric (Infant).
- This report offers widespread analysis on Vaccine Key Players (Worldwide) & Forecast (2011 – 2022)
1 RESEARCH FINDINGS
2 GLOBAL – VACCINES MARKET AND FORECAST
2.1 Adult Vaccines Market and Forecast
2.2 Pediatric (Infant) Vaccines Market and Forecast
3 GLOBAL – ADULT VACCINE VS. PEDIATRIC VACCINE MARKET SHARE
4 GLOBAL – VACCINES MARKET SHARE AND FORECAST
4.1 Adult Vaccines Market Share and Forecast
4.2 Pediatric (Infant) Vaccines Market Share and Forecast
5 GLOBAL – PEOPLE IMMUNIZED AND FORECAST
5.1 Adult Immunized and Forecast
5.2 Pediatric (Infant) Immunized and Forecast
6 GLOBAL – PEOPLE IMMUNIZED SHARE AND FORECAST
6.1 Adult Immunized Share and Forecast
6.2 Pediatric (Infant) Immunized Share and Forecast
7 GLOBAL – DOSES OF VACCINES ADMINISTERED AND FORECAST
7.1 Doses of Adult Vaccines Administered and Forecast
7.2 Doses of Pediatric (Infant) Vaccines Administered and Forecast
8 GLOBAL – DOSES OF VACCINES ADMINISTERED SHARE AND FORECAST
8.1 Doses of Vaccines Administered to Adult Share and Forecast
8.2 Doses of Vaccines Administered to Pediatric (Infant) Share and Forecast
9 GLOBAL – VACCINE COMPANIES MARKET SHARE AND FORECAST
10 DISEASE WISE – VACCINES MARKET AND FORECAST
10.1 Influenza – Total Vaccines Market and Forecast
10.1.1 Influenza – Adult Vaccines Market and Forecast
10.1.2 Influenza – Pediatric (Infant) Vaccines Market and Forecast
10.2 Cervical Cancer (HPV) – Vaccines Market and Forecast
10.3 Zoster (Shingles) – Vaccines Market and Forecast
10.4 MMRV and MMR (Measles, Mumps, Rubella, and Varicella Vaccine) – Total Vaccines Market and Forecast
10.4.1 MMRV – Adult Vaccines Market and Forecast
10.4.2 MMR – Pediatric (Infant) Vaccines Market and Forecast
10.5 Pneumococcal – Total Vaccines Market and Forecast
10.5.1 Pneumococcal – Adult Vaccines Market and Forecast
10.5.2 Pneumococcal – Pediatric (Infant) Vaccines Market and Forecast
10.6 Meningococcal – Total Vaccines Market and Forecast
10.6.1 Meningococcal – Adult Vaccines Market and Forecast
10.6.2 Meningococcal – Pediatric (Infant) Vaccines Market and Forecast
10.7 Hepatitis – Total Vaccines Market and Forecast
10.7.1 Hepatitis – Adult Vaccines Market and Forecast
10.7.2 Hepatitis – Pediatric (Infant) Vaccines Market and Forecast
10.8 TdaP and DTaP – Total Vaccines Market and Forecast
10.8.1 TdaP – Adult Vaccines Market and Forecast
10.8.2 DTaP – Pediatric (Infant) Vaccines Market and Forecast
10.9 Travel and Miscellaneous – Vaccines Market and Forecast
10.1 Haemophilus Influenzae Type B (HIB) – Vaccines Market and Forecast
10.11 Combos (Combination) – Vaccines Market and Forecast
10.12 Polio – Vaccines Market and Forecast
10.13 Rotavirus – Vaccines Market and Forecast
10.14 Varicella – Vaccines Market and Forecast
11 DISEASE WISE – PEOPLE IMMUNIZED NUMBERS AND FORECAST
11.1 Influenza – Total Number of People Immunized and Forecast
11.1.1 Influenza – Number of Adults Immunized and Forecast
11.1.2 Influenza – Number of Infants Immunized and Forecast
11.2 Cervical Cancer (HPV) – People Immunized and Forecast
11.3 Zoster (Shingles) – Number of People Immunized and Forecast
11.4 MMRV and MMR – Total Number of People Immunized and Forecast
11.4.1 MMRV – Number of Adults Immunized and Forecast
11.4.2 MMR – Number of Pediatric (Infants) Immunized and Forecast
11.5 Pneumococcal – Total Number of People Immunized and Forecast
11.5.1 Pneumococcal – Number of Adults Immunized and Forecast
11.5.2 Pneumococcal – Number of Infants Immunized and Forecast
11.6 Meningococcal – Total Number of People Immunized and Forecast
11.6.1 Meningococcal – Number of Adults Immunized and Forecast
11.6.2 Meningococcal – Number of Infants Immunized and Forecast
11.7 Hepatitis – Total Number of People Immunized and Forecast
11.7.1 Hepatitis – Number of Adults Immunized and Forecast
11.7.2 Hepatitis – Number of Infants Immunized and Forecast
11.8 TdaP and DTaP – Total Number of People Immunized and Forecast
11.8.1 TdaP – Number of Adults Immunized and Forecast
11.8.2 DTaP – Number of Infants Immunized and Forecast
11.9 Hib (Haemophilus Influenzae Type B) – Number of Infants Immunized and Forecast
11.1 Combos (Combination Vaccines) – Number of Infants Immunized and Forecast
11.11 Polio – Number of Infants Immunized and Forecast
11.12 Rotavirus – Number of Infants Immunized and Forecast
11.13 Varicella – Number of Infants Immunized and Forecast
12 DISEASE WISE – DOSES OF VACCINES ADMINISTERED AND FORECAST
12.1 Influenza – Doses of Vaccines Administered and Forecast
12.1.1 Influenza – Doses of Adult Vaccines Administered and Forecast
12.1.2 Influenza – Doses of Infant Vaccines Administered and Forecast
12.2 Cervical Cancer (HPV) – Doses of Vaccines Administered and Forecast
12.3 Zoster (Shingles) – Doses of Vaccines Administered and Forecast
12.4 MMRV and MMR – Doses of Vaccines Administered and Forecast
12.4.1 MMRV – Doses of Adult Vaccines Administered and Forecast
12.4.2 MMR – Doses of Infant Vaccines Administered and Forecast
12.5 Pneumococcal – Doses of Vaccines Administered and Forecast
12.5.1 Pneumococcal – Doses of Adult Vaccines Administered and Forecast
12.5.2 Pneumococcal – Doses of Infant Vaccines Administered and Forecast
12.6 Meningococcal – Doses of Vaccines Administered and Forecast
12.6.1 Meningococcal – Doses of Adult Vaccines Administered and Forecast
12.6.2 Meningococcal – Doses of Infant Vaccines Administered and Forecast
12.7 Hepatitis – Doses of Vaccines Administered and Forecast
12.7.1 Hepatitis – Doses of Adult Vaccines Administered and Forecast
12.7.2 Hepatitis – Doses of Infant Vaccines Administered and Forecast
12.8 TdaP and DTaP – Doses of Vaccines Administered and Forecast
12.8.1 TdaP – Doses of Adult Vaccines Administered and Forecast
12.8.2 DTaP – Doses of Infant Vaccines Administered and Forecast
12.9 Hib (Haemophilus Influenzae Type B) – Doses of Infant Vaccines Administered and Forecast
12.1 Polio – Doses of Infant Vaccines Administered and Forecast
12.11 Rotavirus – Doses of Infant Vaccines Administered and Forecast
12.12 Varicella – Doses of Infant Vaccines Administered and Forecast
13 DISEASE WISE - IMMUNIZATION PROFILE
13.1 Immunization Coverage (%) in Infants (2005 – 2015)
13.2 Global Immunization Profile (2011 – 2015)
13.3 Regional Immunization Profile (2001 – 2015)
13.3.1 Measles – Number of Cases Reported
13.3.2 Mumps – Number of Cases Reported
13.3.3 Rubella – Number of Cases Reported
13.3.4 Rubella (CRS) – Number of Cases Reported
13.3.5 Diphtheria – Number of Cases Reported
13.3.6 Tetanus (Neonatal) – Number of Cases Reported
13.3.7 Tetanus (Total) – Number of Cases Reported
13.3.8 Pertussis – Number of Cases Reported
13.3.9 Polio – Number of Cases Reported
13.3.10 Yellow Fever – Number of Cases Reported
13.3.11 Japanese encephalitis – Number of Cases Reported, 2006 - 2015
14 VACCINES KEY PLAYERS SALES AND FORECAST
14.1 GlaxoSmithKline, plc.’s Vaccines Sales and Forecast
14.2 Merck & Co. Vaccines Sales and Forecast
14.3 Sanofi Pasteur’s (France) Vaccines Sales and Forecast
14.4 Worldwide - Pfizer, Inc.’s Vaccines Sales and Forecast
14.5 Worldwide - Others Vaccines Sales and Forecast
15 VACCINES – PRODUCTS AND PIPELINE
15.1 GSK Vaccine Product Pipeline
15.2 Merck Vaccine Product Pipeline
15.3 Sanofi Vaccine Product Pipeline
15.4 Pfizer Vaccine Product Pipeline
16 TOP MERGERS AND ACQUISITIONS IN THE VACCINE INDUSTRY
17 VACCINES AND REGULATOR’S INTERVENTIONS
17.1 Making and Meeting Standards of Quality and Safety
17.2 Vaccine Funding
18 VACCINE MARKET DRIVERS
18.1 Inclusion in National Immunization Schedule
18.2 Growing Immunization Coverage for HPV Vaccines
18.3 Increase in Prevalence of Infectious Diseases
18.4 Global Immunization Vision and Strategy (GIVS)
18.5 GAVI Model Fuelling Vaccine Manufacturers
18.5.1 The Partnership Model
18.5.2 The Business Model
18.6 Increasing Vaccine Availability in United States
18.7 The Vaccine Safety Data link Project
18.8 The Vaccine Injury Compensation Program
18.9 Transforming of Vaccine Technologies
18.1 Global Vaccine Action Plan by WHO (2011 - 2020)
18.11 Continuous Focus on Effective Communication Strategies
19 VACCINES MARKET CHALLENGES
19.1 Hurdles to Optimal use of Licensed Vaccines
19.1.1 Technical Obstacles
19.1.2 Economic Obstacles
19.1.3 Cultural Obstacles
19.2 Complexity of Vaccine Development & Approval System Thwarts Product Development
19.2.1 Legal Obstacles
19.2.2 General Technical Barriers
19.2.3 Economic Barriers
19.2.4 Regulatory Barriers
19.3 Shortening the Timeline for Vaccine Development
19.4 Refusal/Resistance to Vaccination
19.4.1 Vaccine Adverse Event Reporting System
19.5 Vaccine Shortages and Delays
19.6 Obstacles in Vaccine Research & Development
19.7 Barriers to New Entrants in the Vaccines Market
2 GLOBAL – VACCINES MARKET AND FORECAST
2.1 Adult Vaccines Market and Forecast
2.2 Pediatric (Infant) Vaccines Market and Forecast
3 GLOBAL – ADULT VACCINE VS. PEDIATRIC VACCINE MARKET SHARE
4 GLOBAL – VACCINES MARKET SHARE AND FORECAST
4.1 Adult Vaccines Market Share and Forecast
4.2 Pediatric (Infant) Vaccines Market Share and Forecast
5 GLOBAL – PEOPLE IMMUNIZED AND FORECAST
5.1 Adult Immunized and Forecast
5.2 Pediatric (Infant) Immunized and Forecast
6 GLOBAL – PEOPLE IMMUNIZED SHARE AND FORECAST
6.1 Adult Immunized Share and Forecast
6.2 Pediatric (Infant) Immunized Share and Forecast
7 GLOBAL – DOSES OF VACCINES ADMINISTERED AND FORECAST
7.1 Doses of Adult Vaccines Administered and Forecast
7.2 Doses of Pediatric (Infant) Vaccines Administered and Forecast
8 GLOBAL – DOSES OF VACCINES ADMINISTERED SHARE AND FORECAST
8.1 Doses of Vaccines Administered to Adult Share and Forecast
8.2 Doses of Vaccines Administered to Pediatric (Infant) Share and Forecast
9 GLOBAL – VACCINE COMPANIES MARKET SHARE AND FORECAST
10 DISEASE WISE – VACCINES MARKET AND FORECAST
10.1 Influenza – Total Vaccines Market and Forecast
10.1.1 Influenza – Adult Vaccines Market and Forecast
10.1.2 Influenza – Pediatric (Infant) Vaccines Market and Forecast
10.2 Cervical Cancer (HPV) – Vaccines Market and Forecast
10.3 Zoster (Shingles) – Vaccines Market and Forecast
10.4 MMRV and MMR (Measles, Mumps, Rubella, and Varicella Vaccine) – Total Vaccines Market and Forecast
10.4.1 MMRV – Adult Vaccines Market and Forecast
10.4.2 MMR – Pediatric (Infant) Vaccines Market and Forecast
10.5 Pneumococcal – Total Vaccines Market and Forecast
10.5.1 Pneumococcal – Adult Vaccines Market and Forecast
10.5.2 Pneumococcal – Pediatric (Infant) Vaccines Market and Forecast
10.6 Meningococcal – Total Vaccines Market and Forecast
10.6.1 Meningococcal – Adult Vaccines Market and Forecast
10.6.2 Meningococcal – Pediatric (Infant) Vaccines Market and Forecast
10.7 Hepatitis – Total Vaccines Market and Forecast
10.7.1 Hepatitis – Adult Vaccines Market and Forecast
10.7.2 Hepatitis – Pediatric (Infant) Vaccines Market and Forecast
10.8 TdaP and DTaP – Total Vaccines Market and Forecast
10.8.1 TdaP – Adult Vaccines Market and Forecast
10.8.2 DTaP – Pediatric (Infant) Vaccines Market and Forecast
10.9 Travel and Miscellaneous – Vaccines Market and Forecast
10.1 Haemophilus Influenzae Type B (HIB) – Vaccines Market and Forecast
10.11 Combos (Combination) – Vaccines Market and Forecast
10.12 Polio – Vaccines Market and Forecast
10.13 Rotavirus – Vaccines Market and Forecast
10.14 Varicella – Vaccines Market and Forecast
11 DISEASE WISE – PEOPLE IMMUNIZED NUMBERS AND FORECAST
11.1 Influenza – Total Number of People Immunized and Forecast
11.1.1 Influenza – Number of Adults Immunized and Forecast
11.1.2 Influenza – Number of Infants Immunized and Forecast
11.2 Cervical Cancer (HPV) – People Immunized and Forecast
11.3 Zoster (Shingles) – Number of People Immunized and Forecast
11.4 MMRV and MMR – Total Number of People Immunized and Forecast
11.4.1 MMRV – Number of Adults Immunized and Forecast
11.4.2 MMR – Number of Pediatric (Infants) Immunized and Forecast
11.5 Pneumococcal – Total Number of People Immunized and Forecast
11.5.1 Pneumococcal – Number of Adults Immunized and Forecast
11.5.2 Pneumococcal – Number of Infants Immunized and Forecast
11.6 Meningococcal – Total Number of People Immunized and Forecast
11.6.1 Meningococcal – Number of Adults Immunized and Forecast
11.6.2 Meningococcal – Number of Infants Immunized and Forecast
11.7 Hepatitis – Total Number of People Immunized and Forecast
11.7.1 Hepatitis – Number of Adults Immunized and Forecast
11.7.2 Hepatitis – Number of Infants Immunized and Forecast
11.8 TdaP and DTaP – Total Number of People Immunized and Forecast
11.8.1 TdaP – Number of Adults Immunized and Forecast
11.8.2 DTaP – Number of Infants Immunized and Forecast
11.9 Hib (Haemophilus Influenzae Type B) – Number of Infants Immunized and Forecast
11.1 Combos (Combination Vaccines) – Number of Infants Immunized and Forecast
11.11 Polio – Number of Infants Immunized and Forecast
11.12 Rotavirus – Number of Infants Immunized and Forecast
11.13 Varicella – Number of Infants Immunized and Forecast
12 DISEASE WISE – DOSES OF VACCINES ADMINISTERED AND FORECAST
12.1 Influenza – Doses of Vaccines Administered and Forecast
12.1.1 Influenza – Doses of Adult Vaccines Administered and Forecast
12.1.2 Influenza – Doses of Infant Vaccines Administered and Forecast
12.2 Cervical Cancer (HPV) – Doses of Vaccines Administered and Forecast
12.3 Zoster (Shingles) – Doses of Vaccines Administered and Forecast
12.4 MMRV and MMR – Doses of Vaccines Administered and Forecast
12.4.1 MMRV – Doses of Adult Vaccines Administered and Forecast
12.4.2 MMR – Doses of Infant Vaccines Administered and Forecast
12.5 Pneumococcal – Doses of Vaccines Administered and Forecast
12.5.1 Pneumococcal – Doses of Adult Vaccines Administered and Forecast
12.5.2 Pneumococcal – Doses of Infant Vaccines Administered and Forecast
12.6 Meningococcal – Doses of Vaccines Administered and Forecast
12.6.1 Meningococcal – Doses of Adult Vaccines Administered and Forecast
12.6.2 Meningococcal – Doses of Infant Vaccines Administered and Forecast
12.7 Hepatitis – Doses of Vaccines Administered and Forecast
12.7.1 Hepatitis – Doses of Adult Vaccines Administered and Forecast
12.7.2 Hepatitis – Doses of Infant Vaccines Administered and Forecast
12.8 TdaP and DTaP – Doses of Vaccines Administered and Forecast
12.8.1 TdaP – Doses of Adult Vaccines Administered and Forecast
12.8.2 DTaP – Doses of Infant Vaccines Administered and Forecast
12.9 Hib (Haemophilus Influenzae Type B) – Doses of Infant Vaccines Administered and Forecast
12.1 Polio – Doses of Infant Vaccines Administered and Forecast
12.11 Rotavirus – Doses of Infant Vaccines Administered and Forecast
12.12 Varicella – Doses of Infant Vaccines Administered and Forecast
13 DISEASE WISE - IMMUNIZATION PROFILE
13.1 Immunization Coverage (%) in Infants (2005 – 2015)
13.2 Global Immunization Profile (2011 – 2015)
13.3 Regional Immunization Profile (2001 – 2015)
13.3.1 Measles – Number of Cases Reported
13.3.2 Mumps – Number of Cases Reported
13.3.3 Rubella – Number of Cases Reported
13.3.4 Rubella (CRS) – Number of Cases Reported
13.3.5 Diphtheria – Number of Cases Reported
13.3.6 Tetanus (Neonatal) – Number of Cases Reported
13.3.7 Tetanus (Total) – Number of Cases Reported
13.3.8 Pertussis – Number of Cases Reported
13.3.9 Polio – Number of Cases Reported
13.3.10 Yellow Fever – Number of Cases Reported
13.3.11 Japanese encephalitis – Number of Cases Reported, 2006 - 2015
14 VACCINES KEY PLAYERS SALES AND FORECAST
14.1 GlaxoSmithKline, plc.’s Vaccines Sales and Forecast
14.2 Merck & Co. Vaccines Sales and Forecast
14.3 Sanofi Pasteur’s (France) Vaccines Sales and Forecast
14.4 Worldwide - Pfizer, Inc.’s Vaccines Sales and Forecast
14.5 Worldwide - Others Vaccines Sales and Forecast
15 VACCINES – PRODUCTS AND PIPELINE
15.1 GSK Vaccine Product Pipeline
15.2 Merck Vaccine Product Pipeline
15.3 Sanofi Vaccine Product Pipeline
15.4 Pfizer Vaccine Product Pipeline
16 TOP MERGERS AND ACQUISITIONS IN THE VACCINE INDUSTRY
17 VACCINES AND REGULATOR’S INTERVENTIONS
17.1 Making and Meeting Standards of Quality and Safety
17.2 Vaccine Funding
18 VACCINE MARKET DRIVERS
18.1 Inclusion in National Immunization Schedule
18.2 Growing Immunization Coverage for HPV Vaccines
18.3 Increase in Prevalence of Infectious Diseases
18.4 Global Immunization Vision and Strategy (GIVS)
18.5 GAVI Model Fuelling Vaccine Manufacturers
18.5.1 The Partnership Model
18.5.2 The Business Model
18.6 Increasing Vaccine Availability in United States
18.7 The Vaccine Safety Data link Project
18.8 The Vaccine Injury Compensation Program
18.9 Transforming of Vaccine Technologies
18.1 Global Vaccine Action Plan by WHO (2011 - 2020)
18.11 Continuous Focus on Effective Communication Strategies
19 VACCINES MARKET CHALLENGES
19.1 Hurdles to Optimal use of Licensed Vaccines
19.1.1 Technical Obstacles
19.1.2 Economic Obstacles
19.1.3 Cultural Obstacles
19.2 Complexity of Vaccine Development & Approval System Thwarts Product Development
19.2.1 Legal Obstacles
19.2.2 General Technical Barriers
19.2.3 Economic Barriers
19.2.4 Regulatory Barriers
19.3 Shortening the Timeline for Vaccine Development
19.4 Refusal/Resistance to Vaccination
19.4.1 Vaccine Adverse Event Reporting System
19.5 Vaccine Shortages and Delays
19.6 Obstacles in Vaccine Research & Development
19.7 Barriers to New Entrants in the Vaccines Market
LIST OF FIGURES
Figure 2-1: Global – Vaccines Market (Billion US$), 2011 - 2016
Figure 2-2: Global – Forecast for Vaccines Market (Billion US$), 2017 – 2022
Figure 2-3: Global – Adult Vaccines Market (Billion US$), 2011 – 2016
Figure 2-4: Global – Forecast for Adult Vaccines Market (Billion US$), 2017 – 2022
Figure 2-5: Global – Pediatric (Infant) Vaccines Market (Billion US$), 2011 – 2016
Figure 2-6: Global – Forecast for Pediatric (Infant) Vaccines Market (Billion US$), 2017 – 2022
Figure 3-1: Global – Adult Vs. Pediatric Vaccine Market Share
Figure 3-2: Global – Forecast for Adult Vs. Pediatric Vaccine Market Share
Figure 5-1: Global – People Immunized (Million), 2011 - 2016
Figure 5-2: Global – People Immunized (Million), 2017 - 2022
Figure 5-3: Global – Adult Immunized (Million), 2011 – 2016
Figure 5-4: Global – Forecast for Adult Immunized (Million), 2017 – 2022
Figure 5-5: Global – Pediatric (Infant) Immunized (Million), 2011 - 2016
Figure 5-6: Global – Forecast for Pediatric (Infant) Immunized (Million), 2017 – 2022
Figure 7-1: Global – Doses of Vaccines Administered (Million), 2011 - 2016
Figure 7-2: Global – Forecast for Doses of Vaccines Administered (Million), 2017 – 2022
Figure 7-3: Global – Doses of Adult Vaccines Administered (Million), 2011 - 2016
Figure 7-4: Global – Forecast for Doses of Adult Vaccines Administered (Million), 2017 - 2022
Figure 7-5: Global – Doses of Pediatric (Infant) Vaccines Administered (Million), 2011 - 2016
Figure 7-6: Global – Forecast for Doses of Pediatric (Infant) Vaccines Administered (Million), 2017 - 2022
Figure 9-1: Global – Key Players Vaccines Market Share (Percent), 2011 - 2016
Figure 9-2: Global – Forecast for Key Players Vaccines Market Share (Percent), 2017 - 2022
Figure 10-1: Influenza – Total Vaccines Market (Billion US$), 2011 - 2016
Figure 10-2: Influenza – Forecast for Total Vaccines Market (Billion US$), 2017 - 2022
Figure 10-3: Influenza – Adult Vaccines Market (Billion US$), 2011 - 2016
Figure 10-4: Influenza – Forecast for Adult Vaccines Market (Billion US$), 2017 – 2022
Figure 10-5: Influenza – Pediatric (Infant) Vaccines Market (Million US$), 2011 - 2016
Figure 10-6: Influenza – Forecast for Pediatric (Infant) Vaccines Market (Million US$), 2017 - 2022
Figure 10-7: Cervical Cancer (HPV) – Vaccines Market (Billion US$), 2011 – 2016
Figure 10-8: Cervical Cancer (HPV) – Forecast for Vaccines Market (Billion US$), 2017 - 2022
Figure 10-9: Zoster (Shingles) – Vaccines Market (Billion US$), 2011 - 2016
Figure 10-10: Zoster (Shingles) – Forecast for Vaccines Market (Billion US$), 2017 - 2022
Figure 10-11: MMRV and MMR – Total Vaccines Market (Billion US$), 2011 - 2016
Figure 10-12: MMRV and MMR – Forecast for Total Vaccines Market (Billion US$), 2017 – 2022
Figure 10-13: MMRV – Adult Vaccines Market (Million US$), 2011 – 2016
Figure 10-14: MMRV – Forecast for Adult Vaccines Market (Million US$), 2017 – 2022
Figure 10-15: MMR – Pediatric (Infant) Vaccines Market (Million US$), 2011 – 2016
Figure 10-16: MMR – Forecast for Pediatric (Infant) Vaccines Market (Million US$), 2017 - 2022
Figure 10-17: Pneumococcal – Total Vaccines Market (Billion US$), 2011 - 2016
Figure 10-18: Pneumococcal – Forecast for Total Vaccines Market (Billion US$), 2017 - 2022
Figure 10-19: Pneumococcal – Adult Vaccines Market (Billion US$), 2011 - 2016
Figure 10-20: Pneumococcal – Forecast for Adult Vaccines Market (Billion US$), 2017 – 2022
Figure 10-21: Pneumococcal – Pediatric (Infant) Vaccines Market (Billion US$), 2011 - 2016
Figure 10-22: Pneumococcal – Forecast for Pediatric (Infant) Vaccines Market (Billion US$), 2017 - 2022
Figure 10-23: Areas with frequent epidemics of meningococcal meningitis
Figure 10-24: Meningococcal – Total Vaccines Market (Billion US$), 2011 – 2016
Figure 10-25: Meningococcal – Forecast for Total Vaccines Market (Billion US$), 2017 – 2022
Figure 10-26: Meningococcal – Adult Vaccines Market (Million US$), 2011 – 2016
Figure 10-27: Meningococcal – Forecast for Adult Vaccines Market (Million US$), 2017 - 2022
Figure 10-28: Meningococcal – Pediatric (Infant) Vaccines Market (Million US$), 2011 - 2016
Figure 10-29: Meningococcal – Forecast for Pediatric (Infant) Vaccines Market (Million US$), 2017 - 2022
Figure 10-30: Hepatitis – Total Vaccines Market (Billion US$), 2011 - 2016
Figure 10-31: Hepatitis – Forecast for Total Vaccines Market (Billion US$), 2017 - 2022
Figure 10-32: Hepatitis – Adult Vaccines Market (Billion US$), 2011 - 2016
Figure 10-33: Hepatitis – Forecast for Adult Vaccines Market (Billion US$), 2017 - 2022
Figure 10-34: Hepatitis – Pediatric (Infant) Vaccines Market (Million US$), 2011 - 2016
Figure 10-35: Hepatitis – Forecast for Pediatric (Infant) Vaccines Market (Million US$), 2017 - 2022
Figure 10-36: TdaP and DTaP – Total Vaccines Market (Billion US$), 2011 - 2016
Figure 10-37: TdaP and DTaP – Forecast for Total Vaccines Market (Billion US$), 2017 - 2022
Figure 10-38: TdaP – Adult Vaccines Market (Million US$), 2011 - 2016
Figure 10-39: TdaP – Forecast for Adult Vaccines Market (Million US$), 2017 - 2022
Figure 10-40: DTaP – Pediatric (Infant) Vaccines Market (Million US$), 2011 - 2016
Figure 10-41: DTaP – Forecast for Pediatric (Infant) Vaccines Market (Million US$), 2017 - 2022
Figure 10-42: Travel and Miscellaneous – Vaccines Market (Billion US$), 2011 - 2016
Figure 10-43: Travel and Miscellaneous – Forecast for Vaccines Market (Billion US$), 2017 - 2022
Figure 10-44: Haemophilus Influenzae Type B (HIB) – Vaccines Market (Million US$), 2011 - 2016
Figure 10-45: Haemophilus Influenzae Type B (HIB) – Forecast for Vaccines Market (Million US$), 2017 - 2022
Figure 10-46: Combos (Combination) – Vaccines Market (Billion US$), 2011 - 2016
Figure 10-47: Combos (Combination) – Forecast for Vaccines Market (Billion US$), 2017 - 2022
Figure 10-48: Polio – Vaccines Market (Million US$), 2011 - 2016
Figure 10-49: Polio – Forecast for Vaccines Market (Million US$), 2017 - 2022
Figure 10-50: Rotavirus Deaths Under Five Years of Age per 100 000 Population <5 Years of Age, 2013
Figure 10-51: Ten Countries Accounting for Almost Two Thirds of All Deaths, 2013
Figure 10-52: Rotavirus – Vaccines Market (Million US$), 2011 - 2016
Figure 10-53: Rotavirus – Forecast for Vaccines Market (Million US$), 2017 - 2022
Figure 10-54: Varicella – Vaccines Market (Billion US$), 2011 - 2016
Figure 10-55: Varicella – Forecast for Vaccines Market (Billion US$), 2017 – 2022
Figure 11-1: Influenza – Total Number of People Immunized (Million), 2011 - 2016
Figure 11-2: Influenza – Forecast for Total Number of People Immunized (Million), 2017 – 2022
Figure 11-3: Influenza – Number of Adults Immunized (Thousand), 2011 - 2016
Figure 11-4: Influenza – Forecast for Number of Adults Immunized (Thousand), 2017 - 2022
Figure 11-5: Influenza – Number of Infants Immunized (Thousand), 2011 - 2016
Figure 11-6: Influenza – Forecast for Number of Infants Immunized (Thousand), 2017 - 2022
Figure 11-7: Cervical Cancer – Number of People Immunized (Thousand), 2011 - 2016
Figure 11-8: Cervical Cancer – Forecast for Number of People Immunized (Thousand), 2017 - 2022
Figure 11-9: Zoster (Shingles) – Number of People Immunized (Thousand), 2011 - 2016
Figure 11-10: Zoster (Shingles) – Forecast for Number of People Immunized (Thousand), 2017 - 2022
Figure 11-11: MMRV and MMR – Total Number of People Immunized (Million), 2011 - 2016
Figure 11-12: MMRV and MMR – Forecast for Total Number of People Immunized (Million), 2017 - 2022
Figure 11-13: MMRV – Number of Adults Immunized (Thousand), 2011 - 2016
Figure 11-14: MMRV – Forecast for Number of Adults Immunized (Thousand), 2017 - 2022
Figure 11-15: MMR – Number of Pediatric (Infants) Immunized (Thousand), 2011 - 2016
Figure 11-16: MMR – Forecast for Number of Pediatric (Infants) Immunized (Thousand), 2017 - 2022
Figure 11-17: Pneumococcal – Total Number of People Immunized (Million), 2011 - 2016
Figure 11-18: Pneumococcal – Forecast for Total Number of People Immunized (Million), 2017 - 2022
Figure 11-19: Pneumococcal – Number of Adults Immunized (Thousand), 2011 - 2016
Figure 11-20: Pneumococcal – Forecast for Number of Adults Immunized (Thousand), 2017 - 2022
Figure 11-21: Pneumococcal – Number of Infants Immunized (Thousand), 2011 - 2016
Figure 11-22: Pneumococcal – Forecast for Number of Infants Immunized (Thousand), 2011 - 2016
Figure 11-23: Meningococcal – Total Number of People Immunized (Million), 2011 – 2016
Figure 11-24: Meningococcal – Forecast for Total Number of People Immunized (Million), 2017 - 2022
Figure 11-25: Meningococcal – Number of Adults Immunized (Thousand), 2011 - 2016
Figure 11-26: Meningococcal – Forecast for Number of Adults Immunized (Thousand), 2017 - 2022
Figure 11-27: Meningococcal – Number of Infants Immunized (Thousand), 2011 - 2016
Figure 11-28: Meningococcal – Forecast for Number of Infants Immunized (Thousand), 2017 - 2022
Figure 11-29: Hepatitis – Total Number of People Immunized (Million), 2011 - 2016
Figure 11-30: Hepatitis – Forecast for Total Number of People Immunized (Million), 2017 - 2022
Figure 11-31: Hepatitis – Number of Adults Immunized (Thousand), 2011 - 2016
Figure 11-32: Hepatitis – Forecast for Number of Adults Immunized (Thousand), 2017 - 2022
Figure 11-33: Hepatitis – Number of Infants Immunized (Thousand), 2011 - 2016
Figure 11-34: Hepatitis – Forecast for Number of Infants Immunized (Thousand), 2017 - 2022
Figure 11-35: TdaP and DTaP – Total Number of People Immunized (Million), 2011 - 2016
Figure 11-36: TdaP and DTaP – Forecast for Total Number of People Immunized (Million), 2017 - 2022
Figure 11-37: TdaP – Number of Adults Immunized (Thousand), 2011 - 2016
Figure 11-38: TdaP – Number of Adults Immunized (Thousand), 2017 - 2022
Figure 11-39: DTaP – Number of Infants Immunized (Thousand), 2011 - 2016
Figure 11-40: DTaP – Forecast for Number of Infants Immunized (Thousand), 2017 - 2022
Figure 11-41: Hib (Haemophilus Influenzae Type B) – Number of Infants Immunized (Million), 2011 - 2016
Figure 11-42: Hib (Haemophilus Influenzae Type B) – Forecast for Number of Infants Immunized (Million), 2017 - 2022
Figure 11-43: Combos (Combination Vaccines) – Number of Infants Immunized (Million), 2011 - 2016
Figure 11-44: Combos (Combination Vaccines) – Forecast for Number of Infants Immunized (Million), 2017 - 2022
Figure 11-45: Polio – Number of Infants Immunized (Million), 2011 - 2016
Figure 11-46: Polio – Forecast for Number of Infants Immunized (Million), 2017 - 2022
Figure 11-47: Rotavirus – Number of Infants Immunized (Million), 2011 - 2016
Figure 11-48: Rotavirus – Forecast for Number of Infants Immunized (Million), 2017 - 2022
Figure 11-49: Varicella – Number of Infants Immunized (Million), 2011 - 2016
Figure 11-50: Varicella – Forecast for Number of Infants Immunized (Million), 2017 - 2022
Figure 12-1: Influenza – Doses of Vaccines Administered (Million), 2011 - 2016
Figure 12-2: Influenza – Forecast for Doses of Vaccines Administered (Million), 2017 - 2022
Figure 12-3: Influenza – Doses of Adult Vaccines Administered (Million), 2011 - 2016
Figure 12-4: Influenza – Forecast for Doses of Adult Vaccines Administered (Million), 2017 - 2022
Figure 12-5: Influenza – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-6: Influenza – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 12-7: Cervical Cancer (HPV) – Doses of Vaccines Administered (Million), 2011 - 2016
Figure 12-8: Cervical Cancer (HPV) – Forecast for Doses of Vaccines Administered (Million), 2017 - 2022
Figure 12-9: Zoster (Shingles) – Doses of Vaccines Administered (Million), 2011 - 2016
Figure 12-10: Zoster (Shingles) – Forecast for Doses of Vaccines Administered (Million), 2017 - 2022
Figure 12-11: MMRV and MMR – Doses of Vaccines Administered (Million), 2011 - 2016
Figure 12-12: MMRV and MMR – Forecast for Doses of Vaccines Administered (Million), 2017 - 2022
Figure 12-13: MMRV – Doses of Adult Vaccines Administered (Million), 2011 - 2016
Figure 12-14: MMRV – Forecast for Doses of Adult Vaccines Administered (Million), 2017 - 2022
Figure 12-15: MMR – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-16: MMR – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 12-17: Pneumococcal – Doses of Vaccines Administered (Million), 2011 - 2016
Figure 12-18: Pneumococcal – Forecast for Doses of Vaccines Administered (Million), 2017 - 2022
Figure 12-19: Pneumococcal – Doses of Adult Vaccines Administered (Million), 2011 - 2016
Figure 12-20: Pneumococcal – Forecast for Doses of Adult Vaccines Administered (Million), 2017 - 2022
Figure 12-21: Pneumococcal – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-22: Pneumococcal – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 12-23: Meningococcal – Doses of Vaccines Administered (Million), 2011 - 2016
Figure 12-24: Meningococcal – Forecast for Doses of Vaccines Administered (Million), 2017 - 2022
Figure 12-25: Meningococcal – Doses of Adult Vaccines Administered (Million), 2011 - 2016
Figure 12-26: Meningococcal – Forecast for Doses of Adult Vaccines Administered (Million), 2017 - 2022
Figure 12-27: Meningococcal – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-28: Meningococcal – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 12-29: Hepatitis – Doses of Vaccines Administered (Million), 2011 - 2016
Figure 12-30: Hepatitis – Forecast for Doses of Vaccines Administered (Million), 2017 - 2022
Figure 12-31: Hepatitis – Doses of Adult Vaccines Administered (Million), 2011 - 2016
Figure 12-32: Hepatitis – Forecast for Doses of Adult Vaccines Administered (Million), 2017 - 2022
Figure 12-33: Hepatitis – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-34: Hepatitis – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 12-35: TdaP and DTaP – Doses of Vaccines Administered (Million), 2011 - 2016
Figure 12-36: TdaP and DTaP – Forecast for Doses of Vaccines Administered (million), 2017 - 2022
Figure 12-37: TdaP – Doses of Adult Vaccines Administered (Million), 2011 - 2016
Figure 12-38: TdaP – Forecast for Doses of Adult Vaccines Administered (Million), 2017 - 2022
Figure 12-39: DTaP – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-40: DTaP – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 12-41: Hib (Haemophilus Influenzae Type B) – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-42: Hib (Haemophilus Influenzae Type B) – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 12-43: Polio – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-44: Polio – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 12-45: Rotavirus – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-46: Rotavirus – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 12-47: Varicella – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-48: Varicella – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 13-1: Worldwide Immunization Coverage (%) in Infants, 2005- 2010
Figure 13-2: Worldwide Immunization Coverage (%) in Infants, 2011- 2015
Figure 14-1: Worldwide - GlaxoSmithKline, plc.’s Vaccines Sales (Billion US$), 2011 - 2016
Figure 14-2: Worldwide – Forecast for GlaxoSmithKline, plc.’s Vaccines Sales (Billion US$), 2017 - 2022
Figure 14-3: Worldwide - Merck & Co. Vaccines Sales (Billion US$), 2011 - 2016
Figure 14-4: Worldwide – Forecast for Merck & Co. Vaccines Sales (Billion US$), 2017 - 2022
Figure 14-5: Worldwide - Sanofi Pasteur’s Vaccines Sales (Billion US$), 2011 - 2022
Figure 14-6: Worldwide – Forecast for Sanofi Pasteur’s Vaccines Sales (Billion US$), 2017 - 2022
Figure 14-7: Worldwide - Pfizer, Inc.’s Vaccines Sales (Billion US$), 2011 - 2016
Figure 14-8: Worldwide – Forecast for Pfizer, Inc.’s Vaccines Sales (Billion US$), 2017 - 2022
Figure 14-9: Worldwide - Others Vaccines Sales (Billion US$), 2011 - 2016
Figure 14-10: Worldwide – Forecast for Others Vaccines Sales (Billion US$), 2017 - 2022
Figure 15-1: GSK Vaccine Product Pipeline
Figure 18-1: Countries with HPV Vaccination Program listed on their National Immunization Program (NIP) Schedule
Figure 18-2: Number of Cases of Diphtheria, Pertussis, Tetnaus & Measles by Major Region Worldwide, 2013
Figure 18-3: Vaccines Procured by UNICEF: Industrialized and Emerging Market Country Manufacturers
Figure 18-4: Vaccines procured by UNICEF: Industrialized and Emerging Market Country Manufacturers
Figure 18-5: US Retail Clinics Expected to Surge by 2017
Figure 2-1: Global – Vaccines Market (Billion US$), 2011 - 2016
Figure 2-2: Global – Forecast for Vaccines Market (Billion US$), 2017 – 2022
Figure 2-3: Global – Adult Vaccines Market (Billion US$), 2011 – 2016
Figure 2-4: Global – Forecast for Adult Vaccines Market (Billion US$), 2017 – 2022
Figure 2-5: Global – Pediatric (Infant) Vaccines Market (Billion US$), 2011 – 2016
Figure 2-6: Global – Forecast for Pediatric (Infant) Vaccines Market (Billion US$), 2017 – 2022
Figure 3-1: Global – Adult Vs. Pediatric Vaccine Market Share
Figure 3-2: Global – Forecast for Adult Vs. Pediatric Vaccine Market Share
Figure 5-1: Global – People Immunized (Million), 2011 - 2016
Figure 5-2: Global – People Immunized (Million), 2017 - 2022
Figure 5-3: Global – Adult Immunized (Million), 2011 – 2016
Figure 5-4: Global – Forecast for Adult Immunized (Million), 2017 – 2022
Figure 5-5: Global – Pediatric (Infant) Immunized (Million), 2011 - 2016
Figure 5-6: Global – Forecast for Pediatric (Infant) Immunized (Million), 2017 – 2022
Figure 7-1: Global – Doses of Vaccines Administered (Million), 2011 - 2016
Figure 7-2: Global – Forecast for Doses of Vaccines Administered (Million), 2017 – 2022
Figure 7-3: Global – Doses of Adult Vaccines Administered (Million), 2011 - 2016
Figure 7-4: Global – Forecast for Doses of Adult Vaccines Administered (Million), 2017 - 2022
Figure 7-5: Global – Doses of Pediatric (Infant) Vaccines Administered (Million), 2011 - 2016
Figure 7-6: Global – Forecast for Doses of Pediatric (Infant) Vaccines Administered (Million), 2017 - 2022
Figure 9-1: Global – Key Players Vaccines Market Share (Percent), 2011 - 2016
Figure 9-2: Global – Forecast for Key Players Vaccines Market Share (Percent), 2017 - 2022
Figure 10-1: Influenza – Total Vaccines Market (Billion US$), 2011 - 2016
Figure 10-2: Influenza – Forecast for Total Vaccines Market (Billion US$), 2017 - 2022
Figure 10-3: Influenza – Adult Vaccines Market (Billion US$), 2011 - 2016
Figure 10-4: Influenza – Forecast for Adult Vaccines Market (Billion US$), 2017 – 2022
Figure 10-5: Influenza – Pediatric (Infant) Vaccines Market (Million US$), 2011 - 2016
Figure 10-6: Influenza – Forecast for Pediatric (Infant) Vaccines Market (Million US$), 2017 - 2022
Figure 10-7: Cervical Cancer (HPV) – Vaccines Market (Billion US$), 2011 – 2016
Figure 10-8: Cervical Cancer (HPV) – Forecast for Vaccines Market (Billion US$), 2017 - 2022
Figure 10-9: Zoster (Shingles) – Vaccines Market (Billion US$), 2011 - 2016
Figure 10-10: Zoster (Shingles) – Forecast for Vaccines Market (Billion US$), 2017 - 2022
Figure 10-11: MMRV and MMR – Total Vaccines Market (Billion US$), 2011 - 2016
Figure 10-12: MMRV and MMR – Forecast for Total Vaccines Market (Billion US$), 2017 – 2022
Figure 10-13: MMRV – Adult Vaccines Market (Million US$), 2011 – 2016
Figure 10-14: MMRV – Forecast for Adult Vaccines Market (Million US$), 2017 – 2022
Figure 10-15: MMR – Pediatric (Infant) Vaccines Market (Million US$), 2011 – 2016
Figure 10-16: MMR – Forecast for Pediatric (Infant) Vaccines Market (Million US$), 2017 - 2022
Figure 10-17: Pneumococcal – Total Vaccines Market (Billion US$), 2011 - 2016
Figure 10-18: Pneumococcal – Forecast for Total Vaccines Market (Billion US$), 2017 - 2022
Figure 10-19: Pneumococcal – Adult Vaccines Market (Billion US$), 2011 - 2016
Figure 10-20: Pneumococcal – Forecast for Adult Vaccines Market (Billion US$), 2017 – 2022
Figure 10-21: Pneumococcal – Pediatric (Infant) Vaccines Market (Billion US$), 2011 - 2016
Figure 10-22: Pneumococcal – Forecast for Pediatric (Infant) Vaccines Market (Billion US$), 2017 - 2022
Figure 10-23: Areas with frequent epidemics of meningococcal meningitis
Figure 10-24: Meningococcal – Total Vaccines Market (Billion US$), 2011 – 2016
Figure 10-25: Meningococcal – Forecast for Total Vaccines Market (Billion US$), 2017 – 2022
Figure 10-26: Meningococcal – Adult Vaccines Market (Million US$), 2011 – 2016
Figure 10-27: Meningococcal – Forecast for Adult Vaccines Market (Million US$), 2017 - 2022
Figure 10-28: Meningococcal – Pediatric (Infant) Vaccines Market (Million US$), 2011 - 2016
Figure 10-29: Meningococcal – Forecast for Pediatric (Infant) Vaccines Market (Million US$), 2017 - 2022
Figure 10-30: Hepatitis – Total Vaccines Market (Billion US$), 2011 - 2016
Figure 10-31: Hepatitis – Forecast for Total Vaccines Market (Billion US$), 2017 - 2022
Figure 10-32: Hepatitis – Adult Vaccines Market (Billion US$), 2011 - 2016
Figure 10-33: Hepatitis – Forecast for Adult Vaccines Market (Billion US$), 2017 - 2022
Figure 10-34: Hepatitis – Pediatric (Infant) Vaccines Market (Million US$), 2011 - 2016
Figure 10-35: Hepatitis – Forecast for Pediatric (Infant) Vaccines Market (Million US$), 2017 - 2022
Figure 10-36: TdaP and DTaP – Total Vaccines Market (Billion US$), 2011 - 2016
Figure 10-37: TdaP and DTaP – Forecast for Total Vaccines Market (Billion US$), 2017 - 2022
Figure 10-38: TdaP – Adult Vaccines Market (Million US$), 2011 - 2016
Figure 10-39: TdaP – Forecast for Adult Vaccines Market (Million US$), 2017 - 2022
Figure 10-40: DTaP – Pediatric (Infant) Vaccines Market (Million US$), 2011 - 2016
Figure 10-41: DTaP – Forecast for Pediatric (Infant) Vaccines Market (Million US$), 2017 - 2022
Figure 10-42: Travel and Miscellaneous – Vaccines Market (Billion US$), 2011 - 2016
Figure 10-43: Travel and Miscellaneous – Forecast for Vaccines Market (Billion US$), 2017 - 2022
Figure 10-44: Haemophilus Influenzae Type B (HIB) – Vaccines Market (Million US$), 2011 - 2016
Figure 10-45: Haemophilus Influenzae Type B (HIB) – Forecast for Vaccines Market (Million US$), 2017 - 2022
Figure 10-46: Combos (Combination) – Vaccines Market (Billion US$), 2011 - 2016
Figure 10-47: Combos (Combination) – Forecast for Vaccines Market (Billion US$), 2017 - 2022
Figure 10-48: Polio – Vaccines Market (Million US$), 2011 - 2016
Figure 10-49: Polio – Forecast for Vaccines Market (Million US$), 2017 - 2022
Figure 10-50: Rotavirus Deaths Under Five Years of Age per 100 000 Population <5 Years of Age, 2013
Figure 10-51: Ten Countries Accounting for Almost Two Thirds of All Deaths, 2013
Figure 10-52: Rotavirus – Vaccines Market (Million US$), 2011 - 2016
Figure 10-53: Rotavirus – Forecast for Vaccines Market (Million US$), 2017 - 2022
Figure 10-54: Varicella – Vaccines Market (Billion US$), 2011 - 2016
Figure 10-55: Varicella – Forecast for Vaccines Market (Billion US$), 2017 – 2022
Figure 11-1: Influenza – Total Number of People Immunized (Million), 2011 - 2016
Figure 11-2: Influenza – Forecast for Total Number of People Immunized (Million), 2017 – 2022
Figure 11-3: Influenza – Number of Adults Immunized (Thousand), 2011 - 2016
Figure 11-4: Influenza – Forecast for Number of Adults Immunized (Thousand), 2017 - 2022
Figure 11-5: Influenza – Number of Infants Immunized (Thousand), 2011 - 2016
Figure 11-6: Influenza – Forecast for Number of Infants Immunized (Thousand), 2017 - 2022
Figure 11-7: Cervical Cancer – Number of People Immunized (Thousand), 2011 - 2016
Figure 11-8: Cervical Cancer – Forecast for Number of People Immunized (Thousand), 2017 - 2022
Figure 11-9: Zoster (Shingles) – Number of People Immunized (Thousand), 2011 - 2016
Figure 11-10: Zoster (Shingles) – Forecast for Number of People Immunized (Thousand), 2017 - 2022
Figure 11-11: MMRV and MMR – Total Number of People Immunized (Million), 2011 - 2016
Figure 11-12: MMRV and MMR – Forecast for Total Number of People Immunized (Million), 2017 - 2022
Figure 11-13: MMRV – Number of Adults Immunized (Thousand), 2011 - 2016
Figure 11-14: MMRV – Forecast for Number of Adults Immunized (Thousand), 2017 - 2022
Figure 11-15: MMR – Number of Pediatric (Infants) Immunized (Thousand), 2011 - 2016
Figure 11-16: MMR – Forecast for Number of Pediatric (Infants) Immunized (Thousand), 2017 - 2022
Figure 11-17: Pneumococcal – Total Number of People Immunized (Million), 2011 - 2016
Figure 11-18: Pneumococcal – Forecast for Total Number of People Immunized (Million), 2017 - 2022
Figure 11-19: Pneumococcal – Number of Adults Immunized (Thousand), 2011 - 2016
Figure 11-20: Pneumococcal – Forecast for Number of Adults Immunized (Thousand), 2017 - 2022
Figure 11-21: Pneumococcal – Number of Infants Immunized (Thousand), 2011 - 2016
Figure 11-22: Pneumococcal – Forecast for Number of Infants Immunized (Thousand), 2011 - 2016
Figure 11-23: Meningococcal – Total Number of People Immunized (Million), 2011 – 2016
Figure 11-24: Meningococcal – Forecast for Total Number of People Immunized (Million), 2017 - 2022
Figure 11-25: Meningococcal – Number of Adults Immunized (Thousand), 2011 - 2016
Figure 11-26: Meningococcal – Forecast for Number of Adults Immunized (Thousand), 2017 - 2022
Figure 11-27: Meningococcal – Number of Infants Immunized (Thousand), 2011 - 2016
Figure 11-28: Meningococcal – Forecast for Number of Infants Immunized (Thousand), 2017 - 2022
Figure 11-29: Hepatitis – Total Number of People Immunized (Million), 2011 - 2016
Figure 11-30: Hepatitis – Forecast for Total Number of People Immunized (Million), 2017 - 2022
Figure 11-31: Hepatitis – Number of Adults Immunized (Thousand), 2011 - 2016
Figure 11-32: Hepatitis – Forecast for Number of Adults Immunized (Thousand), 2017 - 2022
Figure 11-33: Hepatitis – Number of Infants Immunized (Thousand), 2011 - 2016
Figure 11-34: Hepatitis – Forecast for Number of Infants Immunized (Thousand), 2017 - 2022
Figure 11-35: TdaP and DTaP – Total Number of People Immunized (Million), 2011 - 2016
Figure 11-36: TdaP and DTaP – Forecast for Total Number of People Immunized (Million), 2017 - 2022
Figure 11-37: TdaP – Number of Adults Immunized (Thousand), 2011 - 2016
Figure 11-38: TdaP – Number of Adults Immunized (Thousand), 2017 - 2022
Figure 11-39: DTaP – Number of Infants Immunized (Thousand), 2011 - 2016
Figure 11-40: DTaP – Forecast for Number of Infants Immunized (Thousand), 2017 - 2022
Figure 11-41: Hib (Haemophilus Influenzae Type B) – Number of Infants Immunized (Million), 2011 - 2016
Figure 11-42: Hib (Haemophilus Influenzae Type B) – Forecast for Number of Infants Immunized (Million), 2017 - 2022
Figure 11-43: Combos (Combination Vaccines) – Number of Infants Immunized (Million), 2011 - 2016
Figure 11-44: Combos (Combination Vaccines) – Forecast for Number of Infants Immunized (Million), 2017 - 2022
Figure 11-45: Polio – Number of Infants Immunized (Million), 2011 - 2016
Figure 11-46: Polio – Forecast for Number of Infants Immunized (Million), 2017 - 2022
Figure 11-47: Rotavirus – Number of Infants Immunized (Million), 2011 - 2016
Figure 11-48: Rotavirus – Forecast for Number of Infants Immunized (Million), 2017 - 2022
Figure 11-49: Varicella – Number of Infants Immunized (Million), 2011 - 2016
Figure 11-50: Varicella – Forecast for Number of Infants Immunized (Million), 2017 - 2022
Figure 12-1: Influenza – Doses of Vaccines Administered (Million), 2011 - 2016
Figure 12-2: Influenza – Forecast for Doses of Vaccines Administered (Million), 2017 - 2022
Figure 12-3: Influenza – Doses of Adult Vaccines Administered (Million), 2011 - 2016
Figure 12-4: Influenza – Forecast for Doses of Adult Vaccines Administered (Million), 2017 - 2022
Figure 12-5: Influenza – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-6: Influenza – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 12-7: Cervical Cancer (HPV) – Doses of Vaccines Administered (Million), 2011 - 2016
Figure 12-8: Cervical Cancer (HPV) – Forecast for Doses of Vaccines Administered (Million), 2017 - 2022
Figure 12-9: Zoster (Shingles) – Doses of Vaccines Administered (Million), 2011 - 2016
Figure 12-10: Zoster (Shingles) – Forecast for Doses of Vaccines Administered (Million), 2017 - 2022
Figure 12-11: MMRV and MMR – Doses of Vaccines Administered (Million), 2011 - 2016
Figure 12-12: MMRV and MMR – Forecast for Doses of Vaccines Administered (Million), 2017 - 2022
Figure 12-13: MMRV – Doses of Adult Vaccines Administered (Million), 2011 - 2016
Figure 12-14: MMRV – Forecast for Doses of Adult Vaccines Administered (Million), 2017 - 2022
Figure 12-15: MMR – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-16: MMR – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 12-17: Pneumococcal – Doses of Vaccines Administered (Million), 2011 - 2016
Figure 12-18: Pneumococcal – Forecast for Doses of Vaccines Administered (Million), 2017 - 2022
Figure 12-19: Pneumococcal – Doses of Adult Vaccines Administered (Million), 2011 - 2016
Figure 12-20: Pneumococcal – Forecast for Doses of Adult Vaccines Administered (Million), 2017 - 2022
Figure 12-21: Pneumococcal – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-22: Pneumococcal – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 12-23: Meningococcal – Doses of Vaccines Administered (Million), 2011 - 2016
Figure 12-24: Meningococcal – Forecast for Doses of Vaccines Administered (Million), 2017 - 2022
Figure 12-25: Meningococcal – Doses of Adult Vaccines Administered (Million), 2011 - 2016
Figure 12-26: Meningococcal – Forecast for Doses of Adult Vaccines Administered (Million), 2017 - 2022
Figure 12-27: Meningococcal – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-28: Meningococcal – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 12-29: Hepatitis – Doses of Vaccines Administered (Million), 2011 - 2016
Figure 12-30: Hepatitis – Forecast for Doses of Vaccines Administered (Million), 2017 - 2022
Figure 12-31: Hepatitis – Doses of Adult Vaccines Administered (Million), 2011 - 2016
Figure 12-32: Hepatitis – Forecast for Doses of Adult Vaccines Administered (Million), 2017 - 2022
Figure 12-33: Hepatitis – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-34: Hepatitis – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 12-35: TdaP and DTaP – Doses of Vaccines Administered (Million), 2011 - 2016
Figure 12-36: TdaP and DTaP – Forecast for Doses of Vaccines Administered (million), 2017 - 2022
Figure 12-37: TdaP – Doses of Adult Vaccines Administered (Million), 2011 - 2016
Figure 12-38: TdaP – Forecast for Doses of Adult Vaccines Administered (Million), 2017 - 2022
Figure 12-39: DTaP – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-40: DTaP – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 12-41: Hib (Haemophilus Influenzae Type B) – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-42: Hib (Haemophilus Influenzae Type B) – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 12-43: Polio – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-44: Polio – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 12-45: Rotavirus – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-46: Rotavirus – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 12-47: Varicella – Doses of Infant Vaccines Administered (Million), 2011 - 2016
Figure 12-48: Varicella – Forecast for Doses of Infant Vaccines Administered (Million), 2017 - 2022
Figure 13-1: Worldwide Immunization Coverage (%) in Infants, 2005- 2010
Figure 13-2: Worldwide Immunization Coverage (%) in Infants, 2011- 2015
Figure 14-1: Worldwide - GlaxoSmithKline, plc.’s Vaccines Sales (Billion US$), 2011 - 2016
Figure 14-2: Worldwide – Forecast for GlaxoSmithKline, plc.’s Vaccines Sales (Billion US$), 2017 - 2022
Figure 14-3: Worldwide - Merck & Co. Vaccines Sales (Billion US$), 2011 - 2016
Figure 14-4: Worldwide – Forecast for Merck & Co. Vaccines Sales (Billion US$), 2017 - 2022
Figure 14-5: Worldwide - Sanofi Pasteur’s Vaccines Sales (Billion US$), 2011 - 2022
Figure 14-6: Worldwide – Forecast for Sanofi Pasteur’s Vaccines Sales (Billion US$), 2017 - 2022
Figure 14-7: Worldwide - Pfizer, Inc.’s Vaccines Sales (Billion US$), 2011 - 2016
Figure 14-8: Worldwide – Forecast for Pfizer, Inc.’s Vaccines Sales (Billion US$), 2017 - 2022
Figure 14-9: Worldwide - Others Vaccines Sales (Billion US$), 2011 - 2016
Figure 14-10: Worldwide – Forecast for Others Vaccines Sales (Billion US$), 2017 - 2022
Figure 15-1: GSK Vaccine Product Pipeline
Figure 18-1: Countries with HPV Vaccination Program listed on their National Immunization Program (NIP) Schedule
Figure 18-2: Number of Cases of Diphtheria, Pertussis, Tetnaus & Measles by Major Region Worldwide, 2013
Figure 18-3: Vaccines Procured by UNICEF: Industrialized and Emerging Market Country Manufacturers
Figure 18-4: Vaccines procured by UNICEF: Industrialized and Emerging Market Country Manufacturers
Figure 18-5: US Retail Clinics Expected to Surge by 2017
